Composition
- Active ingredients
- BRIMONIDINE TARTRATE 0.2%; BRINZOLAMIDE 1%
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA204251.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Simbrinza
- Active substance
- brimonidine tartrate
- Drug class
- Other dermatologicals, Sympathomimetics in glaucoma therapy, Sympathomimetics used as decongestants
- Route
- Eye
- Dosage form
- Suspension/drops
- Applicant
- Alcon Labs Inc
- Status
- Prescription
- FDA approval
- 19 Apr 2013
- Application
- NDA204251-001
- RxCUI
- 1421452